Skip to menu Skip to content Skip to footer
Professor Kwun Fong
Professor

Kwun Fong

Email: 

Overview

Background

Kwun is a Thoracic and Sleep Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre (UQTRC). His research interests are focussed on making and translating research discoveries to improving outcomes and the health of people who are affected by lung disease particularly lung cancer screening/early detection and biomarkers. The UQTRC is also passionate at enabling productive collaborations to maximise research impact and scale with contributions to The Cancer Genome Atlas Project, Pan-Cancer Analysis of Whole Genomes (PCAWG), IASLC Lung Cancer Staging Project and others.

Availability

Professor Kwun Fong is:
Available for supervision

Research impacts

Lung cancer is the leading cause of cancer mortality in Australia and globally. The prevention, early detection/screening and optimal management of lung cancer will help address the huge burden from lung cancer, enabled by high impact research and addressing stigma and nihilism and the health disparities that exist.

The team at The Prince Charles Hospital and University of Queensland Thoracic Research Centre are passionate, focussed and internationally recognised, leading clinical research in lung cancer in Australia. They are very pleased and privileged to work with patients, families / carers and consumers to make a difference in this awful disease.

Works

Search Professor Kwun Fong’s works on UQ eSpace

438 works between 1986 and 2025

261 - 280 of 438 works

2012

Conference Publication

Thoracic Digital Tomosynthesis: a Single Centre Experience

Leong, S. C., Bowman, R., V, Yang, I. A., Marshall, H. M., Bennett, J. A. and Fong, K. M. (2012). Thoracic Digital Tomosynthesis: a Single Centre Experience. 4th Australian Lung Cancer Conference, Adelaide Australia, 23-25 August 2012. New York, NY United States: Elsevier .

Thoracic Digital Tomosynthesis: a Single Centre Experience

2012

Conference Publication

Pleural fluid cell-free dna integrity index and mesothelin to identify cytologically negative malignant pleural effusions including mesotheliomas

Sriram, K. B., Relan, V, Clarke, B. E., Duhig, E. E., Windsor, M. N., Matar, K. S., Naidoo, R., Passmore, L., McCaul, E., Courtney, D., Yang, I. A., Bowman, R., V and Fong, K. M. (2012). Pleural fluid cell-free dna integrity index and mesothelin to identify cytologically negative malignant pleural effusions including mesotheliomas. 4th Australian Lung Cancer Conference (ALCC), Adelaide SA, Australia, 23-25 August 2012. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/JTO.0b013e318268ff90

Pleural fluid cell-free dna integrity index and mesothelin to identify cytologically negative malignant pleural effusions including mesotheliomas

2012

Conference Publication

Screening for lung cancer

Fong, K., Marshall, H., Bowman, R., Yang, I., Slaughter, R., Fuentes, M., Crossin, J., Leong, S., Ayres, J., Windsor, M., Redmond, S., McCaul, L., Passmore, L. and Zimmerman, P. (2012). Screening for lung cancer. RACP Future Directions in Health Congress 2012, Brisbane QLD, Australia, 6-9 May 2012. Richmond Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1445-5994.2012.02779.x

Screening for lung cancer

2012

Conference Publication

The application of mitotic activity and necrosis to lung adenocarcinoma and correlation with the Iaslc/ats/ers multidisciplinary classification of adenocarcinoma in stage 1 disease

Duhig, E. E., Clarke, B. E., Godbolt, D., Dettrick, A., Pauli, J., Yang, I. A., Bowman, R., V and Fong, K. M. (2012). The application of mitotic activity and necrosis to lung adenocarcinoma and correlation with the Iaslc/ats/ers multidisciplinary classification of adenocarcinoma in stage 1 disease. 4th Australian Lung Cancer Conference (ALCC), Adelaide SA, Australia, 23-25 August 2012. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/JTO.0b013e318268ff90

The application of mitotic activity and necrosis to lung adenocarcinoma and correlation with the Iaslc/ats/ers multidisciplinary classification of adenocarcinoma in stage 1 disease

2012

Conference Publication

Discovery of new active drugs for treatment of malignant mesothelioma by screening the JHCCL clinical compound library

Relan, V., Schagen, J., Morrison, L., Martins, J., Clarke, B. E., Duhig, E. E., Yang, I. A., Fong, K. M. and Bowman, R. V. (2012). Discovery of new active drugs for treatment of malignant mesothelioma by screening the JHCCL clinical compound library. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings, Canberra ACT, Australia, 30 March-4 April 2012. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2012.02143.x

Discovery of new active drugs for treatment of malignant mesothelioma by screening the JHCCL clinical compound library

2012

Conference Publication

The expression of epithelial mesenchymal transition markers in early stage non-small cell lung cancer

Shaw, E., Wright, C., Bowman, R., V, Yang, I. A., Duhig, E., Clarke, L. and Fong, K. M. (2012). The expression of epithelial mesenchymal transition markers in early stage non-small cell lung cancer. 4th Australian Lung Cancer Conference (ALCC), Adelaide, SA, Australia, 23-25 August 2012. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/JTO.0b013e318268ff90

The expression of epithelial mesenchymal transition markers in early stage non-small cell lung cancer

2012

Journal Article

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas

Sriram, Krishna B., Relan, Vandana, Clarke, Belinda E., Duhig, Edwina E., Windsor, Morgan N., Matar, Kevin S., Naidoo, Rishendran, Passmore, Linda, McCaul, Elizabeth, Courtney, Deborah, Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2012). Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. BMC Cancer, 12 (428) 428, 428-1-428-12. doi: 10.1186/1471-2407-12-428

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas

2012

Conference Publication

Screening lung Tumour tissue for whole genome sequencing

Goh, F., Daniels, M., Shaw, J. G., Courtney, D., Passmore, L., McCaul, L., Duhig, E., Clarke, B., Parsonson, K., Brady, J., Butler, D., Martins, M., Davidson, M., Wright, C. M., Martin, J., Morrison, L., Relan, V, Savarimuthu, F. S. M., Windsor, M. N., Matar, K. S., Naidoo, R., Tam, R., Colosimo, M., Yang, I. A., Bowman, R., V and Fong, K. M. (2012). Screening lung Tumour tissue for whole genome sequencing. 4th Australian Lung Cancer Conference (ALCC), Adelaide, SA, Australia, 23-25 August 2012. Philadelphia, PA, United States: Lippincott Williams and Wilkins. doi: 10.1097/JTO.0b013e318268ff90

Screening lung Tumour tissue for whole genome sequencing

2012

Conference Publication

An evidence-based checklist for acute exacerbations of chronic obstructive pulmonary disease

Goddard, John R., Serginson, John, Mccarthy, Lisa, Waller, Rina, Bowman, Rayleen V., Fong, Kwun M. and Yang, Ian A. (2012). An evidence-based checklist for acute exacerbations of chronic obstructive pulmonary disease. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings, Canberra, ACT, 30 March - 4 April 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2012.02142.x

An evidence-based checklist for acute exacerbations of chronic obstructive pulmonary disease

2012

Conference Publication

Interobserver agreement of lung adenocarcinoma diagnosis when applying the 2011 Iaslc/ats/ers Multidisciplinary Classification of Lung Adenocarcinoma

Duhig, E. E., Clarke, B. E., Godbolt, D., Dettrick, A., Pauli, J., Yang, I. A., Bowman, R., V and Fong, K. M. (2012). Interobserver agreement of lung adenocarcinoma diagnosis when applying the 2011 Iaslc/ats/ers Multidisciplinary Classification of Lung Adenocarcinoma. 4th Australian Lung Cancer Conference (ALCC), Adelaide SA, Australia, 23-25 August 2012. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/JTO.0b013e318268ff90

Interobserver agreement of lung adenocarcinoma diagnosis when applying the 2011 Iaslc/ats/ers Multidisciplinary Classification of Lung Adenocarcinoma

2011

Journal Article

Screening for activating EGFR mutations in surgically resected non-small cell lung cancer

Sriram, Krishna B., Tan, Maxine E., Savarimuthu, Santiyagu M., Wright, Casey M., Relan, Vandana, Stockwell, Rebecca E., Clarke, Belinda E., Duhig, Edwina E., Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2011). Screening for activating EGFR mutations in surgically resected non-small cell lung cancer. European Respiratory Journal, 38 (4), 903-910. doi: 10.1183/09031936.00190110

Screening for activating EGFR mutations in surgically resected non-small cell lung cancer

2011

Journal Article

Diagnostic molecular biomarkers for malignant pleural effusions

Sriram, Krishna B., Relan, Vandana, Clarke, Belinda E., Duhig, Edwina E., Yang, Ian A., Bowman, Rayleen V., Lee, Y.C. Gary and Fong, Kwun M. (2011). Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncology, 7 (6), 737-752. doi: 10.2217/FON.11.45

Diagnostic molecular biomarkers for malignant pleural effusions

2011

Journal Article

Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?

Blinman, Prunella, McLachlan, Sue-Anne, Nowak, Anna K., Duric, Vlatka M., Brown, Chris, Wright, Gavin, Millward, Michael, Fong, Kwun and Stockler, Martin R. (2011). Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?. Lung Cancer, 72 (2), 213-218. doi: 10.1016/j.lungcan.2010.08.007

Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?

2011

Journal Article

Common pathogenic mechanisms and pathways in the development of COPD and lung cancer

Yang, Ian A., Relan, Vandana, Wright, Casey M., Davidson, Morgan R., Sriram, Krishna B., Savarimuthu Francis, Santiyagu M., Clarke, Belinda E., Duhig, Edwina E., Bowman, Rayleen V. and Fong, Kwun M. (2011). Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opinion on Therapeutic Targets, 15 (4), 439-456. doi: 10.1517/14728222.2011.555400

Common pathogenic mechanisms and pathways in the development of COPD and lung cancer

2011

Journal Article

Journal of Thoracic Oncology: Foreword

Fong, Kwun and Mitchell, Paul (2011). Journal of Thoracic Oncology: Foreword. Journal of Thoracic Oncology, 6 (3 SUPPL.1). doi: 10.1097/JTO.0b013e31820ed6bf

Journal of Thoracic Oncology: Foreword

2011

Journal Article

Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD

Savarimuthu Francis, Santiyagu M., Larsen, Jill E., Pavey, Sandra J., Duhig, Edwina E., Clarke, Belinda E., Bowman, Rayleen V., Hayward, Nick K., Fong, Kwun M. and Yang, Ian A. (2011). Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD. PLoS One, 6 (3) e17442, e17442. doi: 10.1371/journal.pone.0017442

Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD

2011

Journal Article

Genomic medicine in non-small cell lung cancer: Paving the path to personalized care

Sriram, K.B., Larsen, J.E., Yang, I.A., Bowman, R.V. and Fong, K.M. (2011). Genomic medicine in non-small cell lung cancer: Paving the path to personalized care. Respirology, 16 (2), 257-263. doi: 10.1111/j.1440-1843.2010.01892.x

Genomic medicine in non-small cell lung cancer: Paving the path to personalized care

2011

Conference Publication

Improving lung cancer specific outcome when access is the key-are we there yet?

Lwin, Zarnie, Day, Heather, Baade, Peter D., Aitken, Joanne F., Yang, Ian A., Bowman, Rayleen and Fong, Kwun M. (2011). Improving lung cancer specific outcome when access is the key-are we there yet?. In: , , (S1390-S1391). .

Improving lung cancer specific outcome when access is the key-are we there yet?

2011

Conference Publication

The lung cancer journey - a review from the prince charles hospital pulmonary malignancy unit

Rassam, L. J., Sinhal, N. P., Mackenzie, H., Bowman, R. V., Fong, K. M., Yang, I. A., Pratt, G., Fay, M., Hughes, B., Windsor, M. F. and Matar, K. (2011). The lung cancer journey - a review from the prince charles hospital pulmonary malignancy unit. 3rd Australian Lung Cancer Conference (ALCC), Melbourne VIC, Australia, 6-8 October 2011. Philadelphia PA, United States: Lippincott Willams & Wilkins. doi: 10.1097/01.JTO.0000394634.73009.dc

The lung cancer journey - a review from the prince charles hospital pulmonary malignancy unit

2011

Conference Publication

Systematic quantification of tumour content in cryopreserved samples stored in a lung tumour bank

Duhig, Edwina, Clarke, Belinda, Martins, Maria, Goh, Felicia, Yang, Ian, Matar, Kevin, Windsor, Morgan, Zimmerman, Paul, Davidson, Morgan, Wright, Casey, Bowman, Rayleen and Fong, Kwun M. (2011). Systematic quantification of tumour content in cryopreserved samples stored in a lung tumour bank. *, *, *. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

Systematic quantification of tumour content in cryopreserved samples stored in a lung tumour bank

Funding

Current funding

  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant

Supervision

Availability

Professor Kwun Fong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Principal Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Principal Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Combined Compressed sensing and machine learning/deep learning methods for rapid MRI

    Associate Advisor

    Other advisors: Associate Professor Henry Marshall, Dr Hongfu Sun, Professor Feng Liu

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Associate Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Effectiveness of Non-invasive Ventilation for the treatment of nocturnal hypoventilation in Myotonic Dystrophy

    Associate Advisor

    Other advisors: Professor Elizabeth Coulson

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture and low bone density in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Doctor Philosophy

    Biomarkers of lung cancer

    Associate Advisor

    Other advisors: Professor Ian Yang

Completed supervision

Media

Enquiries

For media enquiries about Professor Kwun Fong's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au